Dec 23, 2025
After A 4.3% GDP Boom, Traders Bet US Economy Cools Next

The U.S. economy just delivered a blockbuster third quarter, but traders are already betting that the pace will start to cool sharply. SPY ETF is trading near record highs. Check live chart here. Prediction markets reacted quickly after the stronger-than-expected…

Dec 23, 2025
Red Cat Holdings Stock Is Trending Today: Here’s Why

Red Cat Holdings Inc (NASDAQ:RCAT) shares are bouncing around Tuesday following a rally that has seen shares climb 25% over the past five trading sessions. Here’s what’s to know. Red Cat Holdings stock is trending lower. Why is RCAT stock retreating?…

Dec 23, 2025
What’s Up With The Rise In Amazon Stock Today?

Amazon.com Inc (NASDAQ:AMZN) shares are trading higher on Tuesday. Here’s what you should know. Amazon stock is showing upward movement. Why are AMZN shares climbing? What To Know: Amazon may be benefiting from reports that Nvidia Corp (NASDAQ:NVDA) is restructuring its cloud…

Dec 23, 2025
Santa Claus Rally Favors These 5 Stocks, History Says

As traders enter the final trading week of the year, one familiar question dominates Wall Street chatter: Will the Santa Claus Rally show up again? • Newmont stock is trading near recent highs. What should traders watch with NEM? History says…

Dec 23, 2025
What’s Going On With Cipher Mining (CIFR) Stock Today?

Shares of Cipher Mining Inc. (NASDAQ:CIFR) are moving Tuesday. Here’s why the data center company’s stock is trending. Cipher Mining stock is under selling pressure. What’s driving CIFR stock lower? What To Know: Cipher, which manages industrial-scale data centers for Bitcoin…

Dec 23, 2025
Intuitive Machines Stock Cools Down As Space Sector Takes A Breather

Intuitive Machines Inc (NASDAQ:LUNR) shares are trading lower on Tuesday as space-related stocks pull back following Monday’s rally. Intuitive Machines stock is taking a hit today. What’s pressuring LUNR stock? What Happened: The pullback comes after a sharp surge in space…

Dec 23, 2025
Pfizer Reports Patient Death In Marstacimab Hemophilia Extension Study

Pfizer Inc. (NYSE:PFE) disclosed the death of a participant in a long-term open-label extension study of marstacimab in patients with hemophilia A or B. In October 2024, the FDA approved Pfizer’s Hympavzi (marstacimab-hncq) for routine prophylaxis to prevent or reduce…